Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/news
Clear filters and search
Format
photo
Tags
business finance
eli lilly
eli lilly and company
health medical pharma
novo nordisk
pharmaceutical industry
research and development in the united states
tirzepatide
american pharmaceutical company
anti obesity medication
bruce gil
cvs
cvs health
david ricks
eli lilly and
fda
peptide hormones
peptide therapeutics
ro
semaglutide
us food and drug administration
wegovy
zepbound
What
billion
2
×
drugs
eli
expectations
2
×
lilly
loss
mounjaro
outlook
pharma
quarter
raising
2
×
resulting
sales
second
2
×
weight
year
zepbound
analysts
blew
blockbuster
can’t
company’s
conversely
cvs
diabetes
failed
giant
highly
hot
increased
leadership
lilly’s
meet
miss
news
nordisk
novo
outperformed
ozempic
past
Language
unset
Current search:
raising
×
second
×
billion
×
expectations
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}